NLM DIR Seminar Schedule
UPCOMING SEMINARS
-
March 25, 2025 Yifan Yang
TBD -
April 1, 2025 Roman Kogay
TBD -
April 8, 2025 Jaya Srivastava
TBD -
April 15, 2025 Pascal Mutz
TBD -
April 18, 2025 Valentina Boeva, Department of Computer Science, ETH Zurich
Decoding tumor heterogeneity: computational methods for scRNA-seq and spatial omics
RECENT SEMINARS
-
March 11, 2025 Sofya Garushyants
Tmn – bacterial anti-phage defense system -
March 4, 2025 Sanasar Babajanyan
Evolution of antivirus defense in prokaryotes depending on the environmental virus load -
Feb. 25, 2025 Zhizheng Wang
GeneAgent: Self-verification Language Agent for Gene Set Analysis using Domain Databases -
Feb. 18, 2025 Samuel Lee
Efficient predictions of alternative protein conformations by AlphaFold2-based sequence association -
Feb. 11, 2025 Po-Ting Lai
Enhancing Biomedical Relation Extraction with Directionality
Scheduled Seminars on March 1, 2023
Contact NLMDIRSeminarScheduling@mail.nih.gov with questions about this seminar.
Abstract:
Understanding biological networks and how alterations in those networks drive human disease is key to novel treatment strategies. I will give an overview of several methods and resources focused on understanding complex diseases through the lens of network biology. A major topic will be the development and application of the Pathway Commons (PC) molecular interaction resource. PC is based on community-generated formats and ontologies for the representation of biological data (i.e., the Biological Pathway Exchange format and the Systems Biology Graphical Notation). More recent PC development has broadened into areas of crowdsourcing and natural language processing in order to scale with the increase of scientific publishing. I will also cover the use of PC in the creation of drug resistance prediction algorithms and the interpretation of experimental results in the context of biological networks. Additionally, I will discuss work done in collaboration with the National Cancer Institute (NCI) and National Center for Advancing Translational Sciences (NCATS) to structure large data collections. This work helps bridge experimental model systems and patient data for the development of predictive drug response models and the identification of biomarkers and biological process signatures relevant to treatment decisions.